Press Release
The partners have agreed to co-develop and market a portfolio of CRISPR QC products and services for quality control (QC) of CRISPR research,...
Meeting
We are looking forward to meet all the members of the NIST - Genome Editing Consortium in US May 3rd. Our Co-founder and Scientific Advisor, Eric Paul...
Corporate
To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.
We are excited to announce that we have become member of the NIST - Genome Editing Consortium in US.
Finally we can share with you all our new website - www.cobotechnologies.com.
